DTIL: Precision BioSciences, Inc. Stock

by  •  • Comments Off on DTIL: Precision BioSciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 47.69
Enterprise Value ($M) -15.89
Book Value ($M) 56.39
Book Value / Share 5.38
Price / Book 0.85
NCAV ($M) 14.99
NCAV / Share 1.43
Price / NCAV 3.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.59

Liquidity (mrq)
Quick Ratio 6.34
Current Ratio 6.34

Balance Sheet (mrq) ($M)
Current Assets 94.99
Assets 136.39
Liabilities 80.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 68.70
Operating Income -26.16
Net Income 7.17
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -58.45
Cash from Investing -0.21
Cash from Financing 50.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Tang Capital Management Llc 6.40 8.02
04-25 13G/A Highbridge Capital Management Llc 3.70 0.00
03-26 13G Readout Capital, LP 8.90
03-18 13G Weinstein Benjamin 5.20
02-14 13G Lynx1 Capital Management LP 9.99
02-14 13G/A Aquilo Capital Management, LLC 9.90 19.50
02-14 13G/A Janus Henderson Group Plc 0.00 -100.00
02-12 13G/A Novartis Pharma Ag 5.40 -96.67
11-14 13G/A Perceptive Advisors Llc 5.90 -14.74

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q Servier Program Purchase Agreement On April 9, 2021, the Company entered into a program purchase agreement (the “Program Purchase Agreement”) with Les Laboratoires Servier and Institut de Recherches Internationales Servier (collectively, “Servier”),
2025-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 29,048 177,948 16.32
2025-05-14 23,194 87,970 26.37
2025-05-13 6,458 42,541 15.18
2025-05-12 8,167 76,939 10.61

(click for more detail)

Similar Companies
DRMA – Dermata Therapeutics, Inc. DRRX – DURECT Corporation
DRUG – Bright Minds Biosciences Inc. DWTX – Dogwood Therapeutics, Inc.
DYAI – Dyadic International, Inc.


Financial data and stock pages provided by
Fintel.io